ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

AGEN Agenus Inc

13.54
0.28 (2.11%)
最終更新日: 22:50:00
15分遅延
名称 銘柄コード 市場 種別
Agenus Inc AGEN NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.28 2.11% 13.54 22:50:00
始値 安値 高値 終値 前日終値
13.52 13.3729 13.9763 13.26
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0120:30BWAgenus Regains Compliance with Nasdaq Minimum Bid Price..
2024/4/2423:00BWBotensilimab/Balstilimab Data in MSS CRC Selected for the..
2024/4/2320:30BWAgenus to Provide First Quarter 2024 Financial Report and..
2024/4/1220:30BWAgenus Announces Updated Phase 1 Data and Progress on..
2024/4/0605:30BWAgenus Announces Reverse Stock Split of Common Stock
2024/3/1420:30BWAgenus Reports Fourth Quarter and Full Year 2023 Results
2024/3/0621:30BWAgenus Announces Preclinical Data on BMS-986442 (AGEN1777)..
2024/3/0606:30BWAgenus Reports Inducement Grants Under Nasdaq Listing Rule..
2024/3/0106:50EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2024/2/2921:30BWAgenus to Provide Corporate Update and Fourth Quarter & Full..
2024/2/2706:24EDGAR2Form DEF 14A - Other definitive proxy statements
2024/2/2621:30BWAgenus to Participate in Leerink Partners Global Biopharma..
2024/2/1522:02EDGAR2Form PRE 14A - Other preliminary proxy statements
2024/2/1522:00EDGAR2Form 8-K - Current report
2024/2/1521:02PRNUSGinkgo Bioworks and SaponiQx Awarded MCDC Contract to..
2024/2/1422:33EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1221:00EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
2024/2/1007:11EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/3122:00EDGAR2Form 8-K - Current report
2024/1/3121:30BWAgenus to Participate in Oppenheimer 34th Annual Healthcare..
2024/1/2223:59BWBotensilimab/Balstilimab Breakthrough Data Presented at..
2024/1/2221:30BWBotensilimab/Balstilimab Breakthrough Data Presented at..
2024/1/0606:30BWAgenus Reports Inducement Grants Under Nasdaq Listing Rule..
2024/1/0421:30BWAgenus to Participate in B. Riley Healthcare Conference
2024/1/0420:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0420:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0420:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2021:30BWBotensilimab/Balstilimab Data in Neoadjuvant Colorectal..
2023/12/1121:30BWAgenus to Receive $25 Million Milestone Payment from Bristol..
2023/12/0906:15EDGAR2Form 8-K - Current report
2023/11/1806:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1006:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0720:30EDGAR2Form 8-K - Current report
2023/11/0720:30BWAgenus Reports Third Quarter 2023 Results
2023/10/2622:05BWAgenus to Provide Third Quarter 2023 Financial Report and..
2023/10/2301:00BWAgenus Unveils New and Updated Botensilimab Data in..
2023/10/2117:15BWESMO 2023: Agenus’ Botensilimab/Balstilimab Combination..
2023/10/1706:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/1020:30BWAgenus Completes Enrollment in Randomized Phase 2 Clinical..
2023/10/0705:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/0520:30BWAgenus To Host BOT/BAL Program Update at ESMO 2023
2023/10/0506:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/0506:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/0506:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/0205:30BWAgenus Reports Inducement Grants Under Nasdaq Listing Rule..
2023/9/0106:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/2906:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/2820:30BWAgenus to Participate in September Investor Conferences
2023/8/2321:00EDGAR2Form 8-K - Current report
2023/8/2321:00BWAgenus Prioritizes Resources to Accelerate Registration and..

最近閲覧した銘柄

Delayed Upgrade Clock